Literature DB >> 24721456

A comprehensive electrocardiographic, molecular, and echocardiographic study of Brugada syndrome: validation of the 2013 diagnostic criteria.

Simone Savastano1, Roberto Rordorf1, Alessandro Vicentini1, Barbara Petracci1, Erika Taravelli2, Silvia Castelletti2, Alessandra D'Errico1, Margherita Torchio3, Cinzia Dossena2, Paola Novara2, Federica Dagradi3, Maurizio Landolina1, Carla Spazzolini3, Lia Crotti4, Peter J Schwartz5.   

Abstract

BACKGROUND: The debate on the diagnostic value of high intercostal spaces (ICSs) and of the number of diagnostic leads in Brugada syndrome (BrS) has been settled by a recent expert consensus statement.
OBJECTIVE: To test the validity, and the underlying anatomy, of the new electrocardiographic (ECG) diagnostic criteria using echocardiographic, molecular, and clinical evidence in 1 clinical study population with BrS.
METHODS: We analyzed 114 patients with BrS and with a spontaneous or drug-induced type 1 ECG pattern recorded in 1 or more right precordial leads in fourth, third, and second ICSs. The right ventricular outflow tract (RVOT) was localized by using echocardiography. All probands were screened on the SCN5A gene.
RESULTS: The percentage of mutation carriers (MCs) and the event rate were similar regardless of the diagnostic ICS (fourth vs high ICSs: MCs 23% vs 19%; event rate 22% vs 28%) and the number of diagnostic leads (1 vs ≥2: MCs 20% vs 22%; event rate 22% vs 27%). The concordance between RVOT anatomical location and the diagnostic ICSs was 86%. The percentage of the diagnostic ECG pattern recorded was significantly increased by the exploration of the ICSs showing RVOT by echocardiography (echocardiography-guided approach vs conventional approach 100% vs 43%; P < .001).
CONCLUSION: The high ICSs are not inferior to the standard fourth ICS for the ECG diagnosis of BrS, and the interindividual variability depends on the anatomical location of the RVOT as assessed by using echocardiography. This approach significantly increases diagnostic sensitivity without decreasing specificity and fully supports the recently published new diagnostic criteria.
Copyright © 2014 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brugada syndrome; Diagnostic criteria; Echocardiography; Electrocardiography; SCN5A

Mesh:

Substances:

Year:  2014        PMID: 24721456     DOI: 10.1016/j.hrthm.2014.04.010

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  10 in total

1.  Sudden Unexplained Death - Treating the Family.

Authors:  Greg Mellor; Elijah R Behr
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-11-29

Review 2.  The Diagnosis, Risk Stratification, and Treatment of Brugada Syndrome.

Authors:  Johannes Steinfurt; Jürgen Biermann; Christoph Bode; Katja E Odening
Journal:  Dtsch Arztebl Int       Date:  2015-06-05       Impact factor: 5.594

3.  2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families.

Authors:  Martin K Stiles; Arthur A M Wilde; Dominic J Abrams; Michael J Ackerman; Christine M Albert; Elijah R Behr; Sumeet S Chugh; Martina C Cornel; Karen Gardner; Jodie Ingles; Cynthia A James; Jyh-Ming Jimmy Juang; Stefan Kääb; Elizabeth S Kaufman; Andrew D Krahn; Steven A Lubitz; Heather MacLeod; Carlos A Morillo; Koonlawee Nademanee; Vincent Probst; Elizabeth V Saarel; Luciana Sacilotto; Christopher Semsarian; Mary N Sheppard; Wataru Shimizu; Jonathan R Skinner; Jacob Tfelt-Hansen; Dao Wu Wang
Journal:  Heart Rhythm       Date:  2020-10-19       Impact factor: 6.343

4.  2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families.

Authors:  Martin K Stiles; Arthur A M Wilde; Dominic J Abrams; Michael J Ackerman; Christine M Albert; Elijah R Behr; Sumeet S Chugh; Martina C Cornel; Karen Gardner; Jodie Ingles; Cynthia A James; Jyh-Ming Jimmy Juang; Stefan Kääb; Elizabeth S Kaufman; Andrew D Krahn; Steven A Lubitz; Heather MacLeod; Carlos A Morillo; Koonlawee Nademanee; Vincent Probst; Elizabeth V Saarel; Luciana Sacilotto; Christopher Semsarian; Mary N Sheppard; Wataru Shimizu; Jonathan R Skinner; Jacob Tfelt-Hansen; Dao Wu Wang
Journal:  J Arrhythm       Date:  2021-04-08

5.  Key clinical features a general internist needs to know about Brugada syndrome: a case-based discussion.

Authors:  WuQiang Fan; Laura Chachula; Yin Wu; Koroush Khalighi
Journal:  J Community Hosp Intern Med Perspect       Date:  2015-06-15

Review 6.  Genetics of inherited primary arrhythmia disorders.

Authors:  Danna A Spears; Michael H Gollob
Journal:  Appl Clin Genet       Date:  2015-09-18

7.  Early Response after Catheter Ablation of the Epicardial Substrate in a Patient with Brugada Syndrome Can Be Predicted by High Precordial Leads.

Authors:  Yae Min Park; Mi Sook Cha; Hanul Choi; Woong Chol Kang; Seung Hwan Han; In Suck Choi; Eak Kyun Shin; Young-Hoon Kim
Journal:  Case Rep Cardiol       Date:  2018-04-29

Review 8.  ArrhythmoGenoPharmacoTherapy.

Authors:  Arpad Tosaki
Journal:  Front Pharmacol       Date:  2020-05-12       Impact factor: 5.810

9.  Case report: Novel SCN4A variant associated with a severe congenital myasthenic syndrome/myopathy phenotype.

Authors:  Veronika M Berghold; Mahmoud Koko; Riccardo Berutti; Barbara Plecko
Journal:  Front Pediatr       Date:  2022-08-26       Impact factor: 3.569

10.  J point elevation in high precordial leads associated with risk of ventricular fibrillation.

Authors:  Yuki Hasegawa; Hiroshi Watanabe; Yasuhiro Ikami; Sou Otsuki; Kenichi Iijima; Nobue Yagihara; Daisuke Izumi; Tohru Minamino
Journal:  Ann Noninvasive Electrocardiol       Date:  2020-12-27       Impact factor: 1.468

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.